Supplementary information
From the following article:
Molecular basis for sunitinib efficacy and future clinical development
Sandrine Faivre, George Demetri, William Sargent & Eric Raymond
Nature Reviews Drug Discovery 6, 734-745 (September 2007)
doi:10.1038/nrd2380
Supplementary information S1 (table)
Summary of adverse events in the Phase III placebo-controlled GIST study (4/2 schedule of treatment administration).
Supplementary information S1 (table) - Download PDF file (168KB)
Download Browser Plugins and Other Applications
Movie files
PDF douments
Text documents
PostScript documents
Flash movies
Audio files
- Apple iTunes (PC or Mac)
- QuickTime Player (PC or Mac)
- Realplayer (PC or Mac)
- Windows Media player (PC only)
